SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,572 Cr | ₹1,531 Cr | ₹1,484 Cr | ₹1,487 Cr | ₹1,443 Cr |
What is the latest Total Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,572 Cr |
| Mar2024 | ₹1,531 Cr |
| Mar2023 | ₹1,484 Cr |
| Mar2022 | ₹1,487 Cr |
| Mar2021 | ₹1,443 Cr |
How is Total Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,572 Cr | 2.68 | |
| Mar2024 | ₹1,531 Cr | 3.19 | |
| Mar2023 | ₹1,484 Cr | -0.19 | |
| Mar2022 | ₹1,487 Cr | 3.02 | |
| Mar2021 | ₹1,443 Cr | - | |
Compare Total Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹8,928.5 Cr | 0.7% | -3% | 14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 0.7% |
-3% |
14.7% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses